The downgrade from Overweight to Equal-Weight by Morgan Stanley indicates a neutral outlook on the stock, suggesting that the analyst believes RSG is fairly valued at its current price. The maintenance of the price target at $199 supports this view, indicating no expected significant price movement in the short term. Therefore, the impact on the stock price is likely to be neutral in the short term.